AI assistant
Sending…
Teva Pharmaceutical Industries Ltd. — Earnings Release 2007
Oct 30, 2007
7082_rns_2007-10-30_b646714a-a194-4d5f-9426-88027859f813.htm
Earnings Release
Open in viewerOpens in your device viewer
_________
C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2529Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267297 , 03-9267281 Fax: 03-9267429E.mail address: [email protected] of transmission: 30/10/2007 Time of broadcast: 08:02 08:00:39
Reference: 2007-02-428119
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on TEVA REPORTS THIRD QUARTER 2007 RESULTS |
| Q307PRcombinedFinal301007_isa.pdf |
| Please find attached a press release announced on today in the U.S. and its unofficial hebrew translation. The binding release is the english version. |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 05/09/2007 |
| - - - |
| Name of the Signatory: : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer |
| Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: [email protected] |